| 1 | [SID103321621] | Active | EC50 | 0.03 | Agonist activity at human TRPA1 expressed in T-REx-HEK293 cells assessed as increase of intracellular calcium level by FDSS assay [AID516893, Type: Literature] | Transient receptor potential cation channel subfamily A member 1 [gi:313104269] |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 103321621 | | CID | 10757 | | Outcome | Active | | EC50 | 0.03 [uM] | | BioAssay | Agonist activity at human TRPA1 expressed in T-REx-HEK293 cells assessed as increase of intracellular calcium level by FDSS assay | | AID | 516893 | | BioAssay type | Literature | | Target | Transient receptor potential cation channel subfamily A member 1 [gi:313104269] | | PubMed | 20806939 | | Data Table |  |
|
| 2 | [SID103321621] | Active | EC50 | 0.03 | Agonist activity at human TRPA1 expressed in T-REx-HEK293 cells assessed as increase of intracellular calcium level by FDSS assay [AID516893, Type: Literature] | Transient receptor potential cation channel subfamily A member 1 [gi:313104269] |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103321621 | | CID | 10757 | | Outcome | Active | | EC50 | 0.03 [uM] | | BioAssay | Agonist activity at human TRPA1 expressed in T-REx-HEK293 cells assessed as increase of intracellular calcium level by FDSS assay | | AID | 516893 | | BioAssay type | Literature | | Target | Transient receptor potential cation channel subfamily A member 1 [gi:313104269] | | PubMed | 20806939 | | Data Table |  |
|
| 3 | [SID17389975] | Active | Potency | 0.0794 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 0.0794 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 4 | [SID17389975] | Active | Potency | 0.0794 | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) [AID1030, Type: confirmatory] | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 0.0794 [uM] | | BioAssay | qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1) | | AID | 1030 | | BioAssay type | confirmatory | | Target | aldehyde dehydrogenase 1 family, member A1 [Homo sapiens] [gi:30582681] | | PubMed | | | Data Table |  |
|
| 5 | [SID17389975] | Active | Potency | 6.3096 | Cell Viability - LYMP2-022 [AID987, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 6.3096 [uM] | | BioAssay | Cell Viability - LYMP2-022 | | AID | 987 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID17389975] | Active | Potency | 7.9433 | Cell Viability - LYMP2-024 [AID988, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | Cell Viability - LYMP2-024 | | AID | 988 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID17389975] | Active | Potency | 7.9433 | Cell Viability - LYMP2-010 [AID981, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | Cell Viability - LYMP2-010 | | AID | 981 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID17389975] | Active | Potency | 7.9433 | Cell Viability - LYMP2-001 [AID921, Type: confirmatory] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | Cell Viability - LYMP2-001 | | AID | 921 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID17389975] | Active | Potency | 7.9433 | Cell Viability - LYMP2-015 [AID971, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | Cell Viability - LYMP2-015 | | AID | 971 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID17389975] | Active | Potency | 7.9433 | Cell Viability - LYMP2-020 [AID986, Type: confirmatory] | |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 7.9433 [uM] | | BioAssay | Cell Viability - LYMP2-020 | | AID | 986 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 11 | [SID17389975] | Active | Potency | 10 | Cell Viability - LYMP2-017 [AID972, Type: confirmatory] | |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Cell Viability - LYMP2-017 | | AID | 972 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 12 | [SID17389975] | Active | Potency | 10 | Cell Viability - LYMP2-019 [AID973, Type: confirmatory] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Cell Viability - LYMP2-019 | | AID | 973 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID17389975] | Active | Potency | 10 | Cell Viability - LYMP2-021 [AID974, Type: confirmatory] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Cell Viability - LYMP2-021 | | AID | 974 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID17389975] | Active | Potency | 10 | Cell Viability - LYMP2-003 [AID965, Type: confirmatory] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Cell Viability - LYMP2-003 | | AID | 965 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID17389975] | Active | Potency | 10 | Cell Viability - LYMP2-004 [AID966, Type: confirmatory] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Cell Viability - LYMP2-004 | | AID | 966 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID17389975] | Active | Potency | 10 | Cell Viability - LYMP2-005 [AID967, Type: confirmatory] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Cell Viability - LYMP2-005 | | AID | 967 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID17389975] | Active | Potency | 10 | Cell Viability - LYMP2-009 [AID968, Type: confirmatory] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Cell Viability - LYMP2-009 | | AID | 968 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID17389975] | Active | Potency | 10 | Cell Viability - LYMP2-007 [AID979, Type: confirmatory] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Cell Viability - LYMP2-007 | | AID | 979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID17389975] | Active | Potency | 10 | Cell Viability - LYMP2-012 [AID982, Type: confirmatory] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Cell Viability - LYMP2-012 | | AID | 982 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID17389975] | Active | Potency | 10 | Cell Viability - LYMP2-016 [AID984, Type: confirmatory] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Cell Viability - LYMP2-016 | | AID | 984 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID17389975] | Active | Potency | 10 | Cell Viability - LYMP2-018 [AID985, Type: confirmatory] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | Cell Viability - LYMP2-018 | | AID | 985 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID17389975] | Active | Potency | 12.5893 | Cell Viability - LYMP2-014 [AID983, Type: confirmatory] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Cell Viability - LYMP2-014 | | AID | 983 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID17389975] | Active | Potency | 12.5893 | Cell Viability - LYMP2-026 [AID989, Type: confirmatory] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Cell Viability - LYMP2-026 | | AID | 989 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID17389975] | Active | Potency | 12.5893 | Cell Viability - LYMP2-008 [AID980, Type: confirmatory] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Cell Viability - LYMP2-008 | | AID | 980 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID17389975] | Active | Potency | 12.5893 | Cell Viability - LYMP2-011 [AID969, Type: confirmatory] | |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Cell Viability - LYMP2-011 | | AID | 969 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 26 | [SID17389975] | Active | Potency | 12.5893 | Cell Viability - LYMP2-023 [AID975, Type: confirmatory] | |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Cell Viability - LYMP2-023 | | AID | 975 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 27 | [SID17389975] | Active | Potency | 12.5893 | Cell Viability - LYMP2-025 [AID976, Type: confirmatory] | |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Cell Viability - LYMP2-025 | | AID | 976 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 28 | [SID17389975] | Active | Potency | 12.5893 | Cell Viability - LYMP2-002 [AID977, Type: confirmatory] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Cell Viability - LYMP2-002 | | AID | 977 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID17389975] | Active | Potency | 12.5893 | Cell Viability - LYMP2-006 [AID978, Type: confirmatory] | |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | Cell Viability - LYMP2-006 | | AID | 978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 30 | [SID17389975] | Active | Potency | 12.5893 | qHTS Assay for Anthrax Lethal Toxin Internalization [AID912, Type: confirmatory] | lethal factor [Bacillus anthracis str. A2012] [gi:21392848] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Anthrax Lethal Toxin Internalization | | AID | 912 | | BioAssay type | confirmatory | | Target | lethal factor [Bacillus anthracis str. A2012] [gi:21392848] | | PubMed | | | Data Table |  |
|
| 31 | [SID17389975] | Active | Potency | 15.8489 | Cell Viability - LYMP2-013 [AID970, Type: confirmatory] | |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | Cell Viability - LYMP2-013 | | AID | 970 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 32 | [SID17389975] | Active | Potency | 16.7855 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 16.7855 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 33 | [SID17389975] | Active | Potency | 16.7855 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 16.7855 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 34 | [SID17389975] | Active | Potency | 16.7855 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 16.7855 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 35 | [SID17389975] | Active | Potency | 16.7855 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 16.7855 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 36 | [SID17389975] | Active | Potency | 16.7855 | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway [AID651802, Type: confirmatory] | Nuclear receptor ROR-gamma [gi:49066040] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 16.7855 [uM] | | BioAssay | qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway | | AID | 651802 | | BioAssay type | confirmatory | | Target | Nuclear receptor ROR-gamma [gi:49066040] | | PubMed | | | Data Table |  |
|
| 37 | [SID17389975] | Active | Potency | 25.1189 | MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells [AID960, Type: confirmatory] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells | | AID | 960 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID17389975] | Active | Potency | 31.6228 | MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells [AID961, Type: confirmatory] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells | | AID | 961 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID17389975] | Active | Potency | 31.6228 | MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells [AID955, Type: confirmatory] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 31.6228 [uM] | | BioAssay | MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells | | AID | 955 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID17389975] | Active | Potency | 35.4813 | qHTS assay for small molecule antagonists of vitamin D receptor signaling [AID588541, Type: confirmatory] | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS assay for small molecule antagonists of vitamin D receptor signaling | | AID | 588541 | | BioAssay type | confirmatory | | Target | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | | PubMed | | | Data Table |  |
|
| 41 | [SID17389975] | Active | Potency | 35.4813 | qHTS assay for small molecule antagonists of vitamin D receptor signaling [AID588541, Type: confirmatory] | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS assay for small molecule antagonists of vitamin D receptor signaling | | AID | 588541 | | BioAssay type | confirmatory | | Target | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | | PubMed | | | Data Table |  |
|
| 42 | [SID17389975] | Active | Potency | 35.4813 | qHTS assay for small molecule antagonists of vitamin D receptor signaling [AID588541, Type: confirmatory] | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS assay for small molecule antagonists of vitamin D receptor signaling | | AID | 588541 | | BioAssay type | confirmatory | | Target | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | | PubMed | | | Data Table |  |
|
| 43 | [SID17389975] | Active | Potency | 35.4813 | qHTS assay for small molecule antagonists of vitamin D receptor signaling [AID588541, Type: confirmatory] | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 35.4813 [uM] | | BioAssay | qHTS assay for small molecule antagonists of vitamin D receptor signaling | | AID | 588541 | | BioAssay type | confirmatory | | Target | vitamin D (1,25- dihydroxyvitamin D3) receptor [Homo sapiens] [gi:216409708] | | PubMed | | | Data Table |  |
|
| 44 | [SID17389975] | Active | Potency | 39.8107 | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling [AID588533, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling | | AID | 588533 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 45 | [SID17389975] | Active | Potency | 39.8107 | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling [AID588533, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling | | AID | 588533 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 46 | [SID17389975] | Active | Potency | 39.8107 | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling [AID588533, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling | | AID | 588533 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 47 | [SID17389975] | Active | Potency | 39.8107 | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling [AID588533, Type: confirmatory] | glucocorticoid receptor [Homo sapiens] [gi:311348376] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | qHTS assay for small molecule antagonists of glucocorticoid receptor signaling | | AID | 588533 | | BioAssay type | confirmatory | | Target | glucocorticoid receptor [Homo sapiens] [gi:311348376] | | PubMed | | | Data Table |  |
|
| 48 | [SID17389975] | Active | Potency | 39.8107 | MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells [AID962, Type: confirmatory] | |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 39.8107 [uM] | | BioAssay | MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells | | AID | 962 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 49 | [SID17389975] | Active | Potency | 50.1187 | MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells [AID946, Type: confirmatory] | |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 17389975 | | CID | 10757 | | Outcome | Active | | Potency | 50.1187 [uM] | | BioAssay | MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells | | AID | 946 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 50 | [SID26752938] | Active | Potency | 61.1306 | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway [AID651741, Type: confirmatory] | NFE2L2 gene product [Homo sapiens] [gi:20149576] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26752938 | | CID | 10757 | | Outcome | Active | | Potency | 61.1306 [uM] | | BioAssay | qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway | | AID | 651741 | | BioAssay type | confirmatory | | Target | NFE2L2 gene product [Homo sapiens] [gi:20149576] | | PubMed | | | Data Table |  |
|